{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"There were 19 Chinese participants who were included in both the global and China cohort which gives a total of 692 participants instead of a total of 673 participants."},"pointOfContact":{"email":"ClinicalTrialTransparency@astrazeneca.com","organization":"AstraZeneca AB","phone":"+46 766 346712","title":"Global Clinical Leader"}}